U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 47

Tests names and labsConditionsGenes, analytes, and microbesMethods

CFHR5 Deletion/Duplication by RT-PCR (2 Day STAT TAT)

Machaon Diagnostics
United States
11
  • D Deletion/duplication analysis

TMA-Complete Genetic Panel 3.0

Machaon Diagnostics
United States
624
  • E Sequence analysis of select exons

Invitae Expanded Renal Disease Panel

Invitae
United States
693388
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFHR5 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Atypical Hemolytic Uremic Syndrome (aHUS) Panel

Centogene AG - the Rare Disease Company
Germany
2325
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

C3 Glomerularopathy Genetic Panel (6 genes) (2 Day STAT TAT)

Machaon Diagnostics
United States
36
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nephropathy due to CFHR5 deficiency, 614809, Autosomal dominant (C3 glomerulonephritis) (CFHR5 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Nephropathy due to CFHR5 deficiency, 614809, Autosomal dominant (C3 glomerulonephritis) (CFHR5 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Invitae Progressive Renal Disease Panel

Invitae
United States
310195
  • D Deletion/duplication analysis

RenalZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
527338
  • C Sequence analysis of the entire coding region

panel Membranoproliferative Glomerulonephritis (CFH,CFI,CFB,C3,MCP(CD46),MLPA CFH operon,CFHR5)

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
67
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFHR5 - atypical hemolytic uremic syndrome (aHUS)

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - transplantation

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - complement-mediated kidney disease

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

panel Membranoproliferative Glomerulonephritis (CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, THBD, DGKE)

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
47
  • C Sequence analysis of the entire coding region

CFHR5 - C3-glomerulopathy

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - dense deposit disease

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - membranoproliferative glomerulonephritis

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - thrombotic microangiopathy

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

CFHR5 - thrombotic thrombocytopenic purpura

Translational Metabolic Laboratory Radboud University Medical Centre
Netherlands
11
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 47

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.